Global Lyophilized Injectable Industry Outlook 2021: Overview, Opportunities, Key Companies and Forecast to 2027
Executive Summary
According to GRD Survey data, the global Lyophilized Injectable market was valued at million US$ in 2020 and is expected to million US$ by the end of 2027, growing at a CAGR of % in the forecast period 2021 and 2027.
This report studies the Lyophilized Injectable market dynamics from angles such as new entries, mergers and acquisitions, fundings, exit and major technology breakthroughs. Market performance is evaluated through market size (Million USD) by players, regions, product types and end industries. This report also studies the global market competition landscape, market drivers and trends, opportunities and challenges, risks and entry barriers, sales channels, distributors and Porter's Five Forces Analysis.
Geographically, this report is segmented into several key regions, with revenue, market share and growth Rate of Lyophilized Injectable in these regions, from 2016 to 2027, covering
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Italy, Spain and Russia, etc.)
Asia-Pacific (China, Japan, Korea, Southeast Asia, India, Australia)
South America (Brazil, Argentina, Colombia, etc.)
Middle East and Africa (Turkey, Saudi Arabia, South Africa, etc.)
Market Snapshot, By Product Type
Single-use Vials
Point-of-Care Reconstitution
Others
Market Snapshot, By Application
Hospitals
Clinics
Others
Market Snapshot, By Region:
North America
United States
Canada
Mexico
Europe
Germany
France
UK
Italy
Russia
Spain
Asia Pacific
China
Japan
Korea
Southeast Asia
India
Australia
Central & South America
Brazil
Argentina
Colombia
Middle East & Africa
Iran
South Africa
Israel
Turkey
Saudi Arabia
Main Market Players Analyzed in this report, including:
Vetter Pharma
Schott AG
Jubilant HollisterStier
BD
Baxter International
B. Braun Melsungen
Aristopharma
The study objectives of this report are:
To study and analyze the global Lyophilized Injectable market size (Million USD) by company, key regions/countries, products and application, history data from 2016 to 2020, and forecast to 2027.
To understand industry structure of Lyophilized Injectable market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To identify the key global Lyophilized Injectable manufacturers and regional typical players, to define, describe and analyze their sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Lyophilized Injectable market with respect to individual growth trends, future prospects, and their contribution to the total market.
To project the value and volume of Lyophilized Injectable submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
In this study, the years considered to estimate the market size of Lyophilized Injectable are as follows:
History Year: 2016-2020
Base Year: 2020
Estimated Year: 2021
Forecast Year 2021 to 2027
This report includes the estimation of market size from top-down approach by analyzing major submarkets and their major driving factors, and verified from bottom-up approaches. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified from primary sources.
For the data information by region, company, type and application, 2020 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Key Stakeholders Considered in the study:
Raw material vendors
Distributors/traders/wholesalers/suppliers
Regulatory authorities, including government agencies and NGO
Commercial research & development (R&D) institutions
Importers and exporters
Government organizations, research organizations, and consulting firms
Trade/Industrial associations
End-use industries
Table of Contents
1 Market Definition & Scope
1.1 Definition & Scope
1.2 Lyophilized Injectable Product Specifications
1.3 Main Events (Entry, M&A, Exit, Technology and Capital Activity)
1.4 Global Lyophilized Injectable Market Performance and Outlook
2 Market Development Performance under COVID-19
2.1 Influencing Factors of Industry Development in the Next Five Years
2.1.1 Drivers
2.1.2 Restraints
2.1.3 Opportunities
2.2 Porter's Five Forces Analysis
2.3 Comparison of Alternatives and Lyophilized Injectable
3 3 Industrial Lift Cycle and Main Buyers Analysis
3.1 Industry Life Cycle Analysis
3.2 Key Buying Industries/Consumers
3.2.1 Major Buyers in Application One
3.2.2 Major Buyers in Application Two
3.2.1 Major Buyers in Application Three
4 Market Segment: by Type
4.1 Lyophilized Injectable Type Introduction
4.1.1 Single-use Vials
4.1.2 Point-of-Care Reconstitution
4.1.3 Others
4.2 Global Lyophilized Injectable Revenue by Type 2016-2021
5 Market Segment: by Application
5.1 Lyophilized Injectable Type Introduction
5.1.1 Hospitals
5.1.2 Clinics
5.1.3 Others
5.2 Global Lyophilized Injectable Revenue by Application 2016-2021
6 Marke Segment: by Region
6.1 Global Lyophilized Injectable Market by Region
6.2 North America Lyophilized Injectable Market 2016-2021
6.3 Europe Lyophilized Injectable Market 2016-2021
6.4 Asia Pacific Lyophilized Injectable Market 2016-2021
6.5 South America Lyophilized Injectable Market 2016-2021
6.6 Middle East and Africa Lyophilized Injectable Market 2016-2021
7 North America
7.1 North America Lyophilized Injectable Market by Country 2016-2021
7.2 United States
7.3 Canada
7.4 Mexico
8 Europe
8.1 Europe Lyophilized Injectable Market by Country 2016-2021
8.2 Germany
8.3 France
8.4 UK
8.5 Italy
8.6 Russia
8.7 Spain
9 Asia Pacific
9.1 Asia Pacific Lyophilized Injectable Market by Country 2016-2021
9.2 China
9.3 Japan
9.4 Korea
9.5 Southeast Asia
9.6 India
9.7 Australia
10 South America
10.1 South America Lyophilized Injectable Market by Country 2016-2021
10.2 Brazil
10.3 Argentina
10.4 Colombia
11 Middle East and Africa
11.1 Middle East and Africa Lyophilized Injectable Market by Country 2016-2021
11.2 Turkey
11.3 Saudi Arabia
11.4 South Africa
12 Key Participants Company Information
3.1 Vetter Pharma
3.1.1 Vetter Pharma Company Information
3.1.2 Vetter Pharma Lyophilized Injectable Product Portfolio, Specification and Application
3.1.3 Vetter Pharma Lyophilized Injectable Revenue and Gross Margin (2019-2021)
3.1.4 Vetter Pharma Key Development
3.2 Schott AG
3.2.1 Schott AG Company Information
3.2.2 Schott AG Lyophilized Injectable Product Portfolio, Specification and Application
3.2.3 Schott AG Lyophilized Injectable Revenue and Gross Margin (2019-2021)
3.2.4 Schott AG Key Development
3.3 Jubilant HollisterStier
3.3.1 Jubilant HollisterStier Company Information
3.3.2 Jubilant HollisterStier Lyophilized Injectable Product Portfolio, Specification and Application
3.3.3 Jubilant HollisterStier Lyophilized Injectable Revenue and Gross Margin (2019-2021)
3.3.4 Jubilant HollisterStier Key Development
3.4 BD
3.4.1 BD Company Information
3.4.2 BD Lyophilized Injectable Product Portfolio, Specification and Application
3.4.3 BD Lyophilized Injectable Revenue and Gross Margin (2019-2021)
3.4.4 BD Key Development
3.5 Baxter International
3.5.1 Baxter International Company Information
3.5.2 Baxter International Lyophilized Injectable Product Portfolio, Specification and Application
3.5.3 Baxter International Lyophilized Injectable Revenue and Gross Margin (2019-2021)
3.5.4 Baxter International Key Development
3.6 B. Braun Melsungen
3.6.1 B. Braun Melsungen Company Information
3.6.2 B. Braun Melsungen Lyophilized Injectable Product Portfolio, Specification and Application
3.6.3 B. Braun Melsungen Lyophilized Injectable Revenue and Gross Margin (2019-2021)
3.6.4 B. Braun Melsungen Key Development
3.7 Aristopharma
3.7.1 Aristopharma Company Information
3.7.2 Aristopharma Lyophilized Injectable Product Portfolio, Specification and Application
3.7.3 Aristopharma Lyophilized Injectable Revenue and Gross Margin (2019-2021)
3.7.4 B. Braun Melsungen Key Development
13 Global Lyophilized Injectable Market Forecast by Region by Type and by Application
13.1 Global Lyophilized Injectable Revenue Forecast 2022-2027
13.2 Global Lyophilized Injectable Forecast by Regions
13.3 Global Lyophilized Injectable Forecast by Type
13.4 Global Lyophilized Injectable Forecast by Application
14 Analyst Views and Conclusions
15 Methodology and Data Source
15.1 Methodology
15.2 Research Data Source
15.2.1 Secondary Data
15.2.2 Primary Data
15.2.3 Market Size Estimation
15.3 Legal Disclaimer
List of Tables
Table 1: Global Lyophilized Injectable Production Specifications
Table 2: Drivers in Lyophilized Injectable Market
Table 3: Restraints Lyophilized Injectable Market
Table 4: Opportunity in Lyophilized Injectable Market
Table 5: Comparion of Alternative and Lyophilized Injectable
Table 6: Lyophilized Injectable Raw Materials Key Suppliers List
Table 7: Lyophilized Injectable Distributors List
Table 8: Lyophilized Injectable Major Buyers in Application One
Table 9: Lyophilized Injectable Major Buyers in Application Two
Table 10: Lyophilized Injectable Major Buyers in Application Three
Table 11: Global Lyophilized Injectable Revenue (Million USD) by Type 2016-2021
Table 12: Global Lyophilized Injectable Revenue Market Share by Type 2016-2021
Table 18: Global Lyophilized Injectable Revenue (Million USD) by Application 2016-2021
Table 19: Global Lyophilized Injectable Revenue Market Share by Application 2016-2021
Table 20: Global Lyophilized Injectable Revenue (Million USD) by Region 2016-2021
Table 21: Global Lyophilized Injectable Revenue Market Share by Region 2016-2021
Table 22: North America Lyophilized Injectable Revenue (Million USD) by Country 2016-2021
Table 23: North America Lyophilized Injectable Revenue Market Share by Country 2016-2021)
Table 24: Europe Lyophilized Injectable Revenue (Million USD) by Country 2016-2021
Table 25: Europe Lyophilized Injectable Revenue Market Share by Country 2016-2021)
Table 26: Asia Pacific Lyophilized Injectable Revenue (Million USD) by Country 2016-2021
Table 27: Asia Pacific Lyophilized Injectable Revenue Market Share by Country 2016-2021)
Table 28: South America Lyophilized Injectable Revenue (Million USD) by Country 2016-2021
Table 29: South America Lyophilized Injectable Revenue Market Share by Country 2016-2021)
Table 30: Middle East and Africa Lyophilized Injectable Revenue (Million USD) by Country 2016-2021
Table 31: Middle East and Africa Lyophilized Injectable Revenue Market Share by Country 2016-2021)
Table 32 Vetter Pharma Company Information
Table 33 Vetter Pharma Lyophilized Injectable Product Portfolio, Specification and Application
Table 34 Vetter Pharma Lyophilized Injectable Revenue and Gross Margin (2019-2021)
Table 35 Schott AG Company Information
Table 36 Schott AG Lyophilized Injectable Product Portfolio, Specification and Application
Table 37 Schott AG Lyophilized Injectable Revenue and Gross Margin (2019-2021)
Table 38 Jubilant HollisterStier Company Information
Table 39 Jubilant HollisterStier Lyophilized Injectable Product Portfolio, Specification and Application
Table 40 Jubilant HollisterStier Lyophilized Injectable Revenue and Gross Margin (2019-2021)
Table 41 BD Company Information
Table 42 BD Lyophilized Injectable Product Portfolio, Specification and Application
Table 43 BD Lyophilized Injectable Revenue and Gross Margin (2019-2021)
Table 44 Baxter International Company Information
Table 45 Baxter International Lyophilized Injectable Product Portfolio, Specification and Application
Table 46 Baxter International Lyophilized Injectable Revenue and Gross Margin (2019-2021)
Table 47 B. Braun Melsungen Company Information
Table 48 B. Braun Melsungen Lyophilized Injectable Product Portfolio, Specification and Application
Table 49 B. Braun Melsungen Lyophilized Injectable Revenue and Gross Margin (2019-2021)
Table 50 Aristopharma Company Information
Table 51 Aristopharma Lyophilized Injectable Product Portfolio, Specification and Application
Table 52 Aristopharma Lyophilized Injectable Revenue and Gross Margin (2019-2021)
Table 59: Global Lyophilized Injectable Revenue (Million USD) Forecast by Region (2022-2027)
Table 60: Global Lyophilized Injectable Revenue Market Share Forecast by Region (2022-2027)
Table 61: Global Lyophilized Injectable Revenue (Million USD) Forecast by Type (2022-2027)
Table 62: Global Lyophilized Injectable Revenue Market Share Forecast by Type (2022-2027)
Table 63: Global Lyophilized Injectable Revenue (Million USD) Forecast by Application (2022-2027)
Table 64: Global Lyophilized Injectable Revenue Market Share Forecast by Application (2022-2027)
Tables and Figures
List of Figures
Figure 1: Lyophilized Injectable Picture
Figure 2: Global Lyophilized Injectable Market Size (Million USD) and Growth Rate (2016-2027)
Figure 3: Porter's Five Forces Analysis
Figure 4: Lyophilized Injectable Industry Life Cycle
Figure 5: Product Picture of Single-use Vials
Figure 6: Product Picture of Point-of-Care Reconstitution
Figure 9: Global Lyophilized Injectable Revenue Market Share by Type, 2020
Reason to Buy
- Current and future of Pharma & Healthcare Market outlook in the developed and emerging markets
- Highlights key business priorities in order to assist companies to realign their business strategies
- The segment that is expected to dominate the Pharma & Healthcare Market
- Regions that are expected to witness the fastest growth during the forecast period
- Identify the latest developments, Pharma & Healthcare Market shares, and strategies employed by the major market players
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Pharma & Healthcare Market
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets